The ENVISION project, funded by USAID and led by RTI International, aimed for the control and elimination of five neglected tropical diseases in the DRC: LF, onchocerciasis, schistosomiasis, STH and trachoma.
In Haiti, IMA was the lead implementing partner and worked alongside the Haiti Neglected Tropical Disease Control Program, a joint effort between the Ministry of Health and Population (MSPP), the Ministry of Education and other partners. IMA helped the government to provide MDA through community posts and schools across Haiti’s 10 departments to treat LF and STH. IMA trained approximately 34,000 community leaders, promoters and distributors to educate the population about LF and STH, persuading the highest number of households possible to participate in MDA and conduct MDA. In Haiti, IMA led the scale-up of nationwide treatment and treated nearly 6 million people annually for LF and STH. Following guidance from the World Health Organization (WHO), IMA and its partners also conducted TAS in communes that have had at least five consecutive MDA at high coverage and a prevalence of MF <1% or Ag <2% in sentinel and spot-check sites.
In Tanzania, IMA collaborated with the Ministry of Health and Social Welfare to eliminate and control five NTDs endemic in Tanzania. IMA coordinated MDA in 19 regions and 134 districts throughout Tanzania, training more than 11,414 front line health workers, 27,087 teachers and 90,284 community drug distributors to support treatment for over 20 million individuals annually. Supporting the World Health Organization’s global control and elimination goals, IMA, along with the Tanzania NTD Control Program, carried out MDA, disease specific assessments (DSAs) and other interventions in all NTD-endemic districts across mainland Tanzania.
In DRC, IMA conducted annual MDA of three medications among more than 500,000 people in six zones in northern Maniema Province in 2015-2016 and in three zones in 2017, with the goal of treating 80% of the population for LF, onchocerciasis, schistosomiasis and STH.